Independent forecasts built on public federal data. Not a U.S. government website.

BIO RAD LABORATORIES INC

BIO RAD LABORATORIES INC has won 284 federal awards worth $11.9M in total across 11 agencies, with a median award of $23K. See where they win and what those contracts close for, and forecast the price on a solicitation you're competing for.

284
awards won
$11.9M
total obligated
$23K
median award
11
agencies

Recent awards

TitleAgencyValueDate
BIOLOGICAL AND REAGENT KITS - LIQUICHEK TUMOR REGEANTSDepartment Of Health And Human Services$61K2026-06-01
QX200 DDPCR SYSTEM AND RENEWAL OF THE SERVICE AGREEMENTEnvironmental Protection Agency$40K2026-05-01
NBAF - BIO-RAD-ANTIBODIESDepartment Of Agriculture$38K2026-04-28
FY26 B5 BIO RAD VARIANT QTR 3Department Of Justice$4K2026-04-14
REAGENTS AND LABORATORY CONSUMABLESDepartment Of Defense$177K2026-03-30

Questions

How many federal contracts has BIO RAD LABORATORIES INC won?

284 awards on record, worth $11.9M in total across 11 agencies. The median award is $23K.

Which agencies buy from BIO RAD LABORATORIES INC?

Mostly Department Of Defense, Department Of Health And Human Services, Department Of Veterans Affairs, among 11 agencies in total.

Is BIO RAD LABORATORIES INC a competitor worth watching?

That depends on your category. This page lists the agencies they win from and their recent awards, so you can see whether they are active in the lanes you bid. AwardCast forecasts the closing price for a specific open solicitation, which is the number that matters when you are bidding against them.

Agencies they win from

279 more awards + the price forecast for any solicitation this contractor is bidding.

Forecast Report — what a specific solicitation will close for: the predicted price range, the competition to expect, and comparable awards already closed. Before you price your bid.

Every forecast is scored against the real award once it becomes public. See the track record.

Get a forecast — $49

$49 per report. No subscription, no account needed to see pricing.